Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 1

TABLE OF CONTENTS Volume 19, Issue 1 (January 2012) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement CANCER GENE THERAPY The Journal of Cancer Gene and Cellular Therapies Submit your research and 110,000+ registered professionals in the field of cancer research and related disciplines will see your paper via the monthly Table of Content e-alerts.   Original Articles Top D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate S M El Sayed, R M Abou El-Magd, Y Shishido, S P Chung, T Sakai, H Watanabe, S Kagami and K Fukui Cancer Gene Ther 2012 19: 1-18; advance online publication, September 16, 2011; 10.1038/cgt.2011.59 Abstract | Full Text Fibroblast growth factor and ornithine decarboxylase 5′UTRs enable preferential expression in human prostate cancer cells and in prostate tumors of PTEN−/− transgenic mice M Moussavi, N Moshgabadi, L Fazli, E Leblanc, K Zhang, W Jia and P S Rennie Cancer Gene Ther 2012 19: 19-29; advance online publication, September 16, 2011; 10.1038/cgt.2011.62 Abstract | Full Text Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function M A Morse, A Hobeika, D Serra, K Aird, M McKinney, A Aldrich, T Clay, D Mourich, H K Lyerly, P L Iversen and G R Devi Cancer Gene Ther 2012 19: 30-37; advance online publication, October 14, 2011; 10.1038/cgt.2011.63 Abstract | Full Text Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy T-J Song, D Haddad, P Adusumilli, T Kim, B Stiles, M Hezel, N D Socci, M Gönen and Y Fong Cancer Gene Ther 2012 19: 38-48; advance online publication, October 21, 2011; 10.1038/cgt.2011.64 Abstract | Full Text Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL X Liu, X Cao, R Wei, Y Cai, H Li, J Gui, D Zhong, X-Y Liu and K Huang Cancer Gene Ther 2012 19: 49-57; advance online publication, October 7, 2011; 10.1038/cgt.2011.67 Abstract | Full Text The chicken chorioallantoic membrane tumor assay as model for qualitative testing of oncolytic adenoviruses F Durupt, D Koppers-Lalic, B Balme, L Budel, O Terrier, B Lina, L Thomas, R C Hoeben and M Rosa-Calatrava Cancer Gene Ther 2012 19: 58-68; advance online publication, October 21, 2011; 10.1038/cgt.2011.68 Abstract | Full Text CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model T Nguyen-Hoai, G Baldenhofer, M S Sayed Ahmed, M Pham-Duc, M D Vu, M Lipp, B Dörken, A Pezzutto and J Westermann Cancer Gene Ther 2012 19: 69-76; advance online publication, October 14, 2011; 10.1038/cgt.2011.69 Abstract | Full Text Advertisement Nature Reviews Genetics ARTICLE SERIES ON NON-CODING RNA Starting December 2011 A series of articles that explores the emerging repertoire and roles of non-coding RNAs, including microRNAs and long non-coding RNAs. Access the Poster FREE online! www.nature.com/nrg/posters/small-rna   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.